Jordan Zinberg on BNN - Don't BUY 1It was caught up with other health care names when COVID hit. The company got a little ahead of itself with the excitement of remote medicine. They raised a lot of capital and acquired a lot of companies. It is a wait-and-see for him. They need to justify the valuation that it is at now. He prefers others.
Unknown whether he owns but given the comments i would say unlikely.